Teresa Macarulla
@macarullateresa
GI Medical Oncologist @VHIO, @vallhebron, @IOBoncologia
ID: 729985645192597508
10-05-2016 10:45:15
387 Tweet
1,1K Takipçi
65 Takip Edilen
CD40 agonist mitazalimab with mFOLFIRINOX in mPDAC. Promising data published in Lancet Oncol. We keep fighting against this disease. # ASCO24; Vall d’Hebron Institute of Oncology (VHIO) The Lancet Oncology
